The content on this site is intended for healthcare professionals only
Prof Greenwood talks to ecancertv at Children with Cancer UK’s workshop on Drug Delivery in Paediatric Brain Tumours in London, UK.
He talks about the role of the blood-brain barrier (BBB) in protecting the brain and how it can be affected by disease such as brain tumours.
Prof Greenwood notes that the BBB is now increasingly considered to be part of a larger structure called the neurovascular unit, which incorporates other brain cells.
The added value of integrative medicine
Blinatumomab added to chemotherapy improves disease-free survival in newly diagnosed NCI standard risk paediatric B-ALL
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Post-diagnosis diet, nutrition and cancer prognosis
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy
